Applicant, as named in the Orange Book

Cytokinetics

Next listed expiry: Myqorzo on 15 Jul 2042. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Myqorzo NDA 219083 · 4 strengths aficamten	aficamten	15 Jul 2042 patent, carve-out possible	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.